Chapter 3. Psychotic Disorders and Contributing Factors in Adolescence


Carmen Cendrero-Luengo¹, María Jiménez-Palomares², PhD, Juan Rodríguez-Mansilla², PhD, María Jesús Rodríguez-Mansilla³, María Trinidad Rodríguez-Domínguez⁴, PhD, and Elisa María Garrido-Ardila², PhD
¹Vithas Hospital, Plácido Fernández Viagas Avenue, Sevilla, Spain
²ADOLOR Research Group, Medical and Surgical Department, Medicine and Health Sciences Faculty, University of Extremadura, Spain
³Don Benito-Villanueva Hospital, Nursing Department, Don Benito, Badajoz, Spain
⁴ROBOLAB Research Group, Medical-Surgical Therapy Department, Nursing and Occupational Therapy Faculty, Extremadura University, Spain

Chapter DOI:

Part of the book: Understanding Psychotic Disorders


Psychotic disorders are severe mental disorders as defined by the current edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V). They are included in the category ‘Schizophrenia spectrum and other psychotic disorders’. According to the report of the European Brain Council (EBC) and the European College of Neuropsycho- pharmacology (ECNP) in terms of prevalence, ‘every year, around 38.2% of the European population suffers from a mental disorder, constituting some 164.7 million people.’ Mental illnesses develop in a continuum process, where there are different phases. In particular, psychotic disorders start with incipient psychosis. The prognosis of psychotic disorders varies in relation to the time of detection and diagnosis of symptoms. It is considered important to detect clinical manifestations early, in order to start the treatment as soon as possible, as delay in starting treatment once symptoms have developed leads to a worse prognosis. Adolescence is a key stage for the development of different mental disorders, particularly psychotic disorders. This stage of life is accompanied by new practices that can make us more vulnerable to suffering from a psychotic disorder or, on the contrary, play a protective role in its evolution. Contributing factors are elements that collaborate in the development of psychotic disorders. In this sense, the main risk factor is age. The World Federation for Mental Health (WFMH) has determined that at least half of all mental health disorders appear at the age of 14, with major depression, bipolar disorder and schizophrenia being the serious mental illnesses that most affect these young people. Knowing about them, detecting them and investigating them is necessary to improve the prognosis of the pathology and to be able to carry out a correct treatment approach.

Keywords: psychotic disorders, adolescence, contributing factors, treatment and prevention


Albert, Nikolai, and Melissa Authen Weibell. 2019. “The Outcome of Early Intervention in
First Episode Psychosis.” Https://Doi.Org/10.1080/09540261.2019.1643703 31 (5–6): 413–24.
American Psychiatric Association – APA. Manual Diagnóstico Y Estadístico De Los
Trastornos Mentales DSM-5 [Diagnostic and Statistical Manual of Mental Disorders
DSM-5]. 5a. ed. –. Madrid: Editorial Médica Panamericana, 2014.
Arseneault, Louise, Mary Cannon, Richie Poulton, Robin Murray, Avshalom Caspi, and
Terrie E. Moffitt. 2002. “Cannabis Use in Adolescence and Risk for Adult Psychosis:
Longitudinal Prospective Study.” BMJ (Clinical Research Ed.) 325 (7374): 1212–13.
Arseneault, Louise, Mary Cannon, John Witton, and Robin M. Murray. 2004. “Causal
Association between Cannabis and Psychosis: Examination of the Evidence.” The
British Journal of Psychiatry : The Journal of Mental Science 184 (FEB.): 110–17.
Azis, Matilda, Pamela Rakhshan Rouhakhtar, Jason E. Schiffman, Lauren M. Ellman,
Gregory P. Strauss, and Vijay A. Mittal. 2021. “Structure of Positive Psychotic
Symptoms in Individuals at Clinical High Risk for Psychosis.” Early Intervention in
Psychiatry 15 (3): 505.
Bouras, N. 2017. “Social Challenges of Contemporary Psychiatry.” Psychiatrike =
Psychiatriki 28 (3): 119–202.
Buchain, Patrícia Cardoso, Adriana Dias Barbosa Vizzotto, Jorge Henna Neto, and Helio
Elkis. 2003. “Randomized Controlled Trial of Occupational Therapy in Patients with
Treatment-Resistant Schizophrenia.” Revista Brasileira de Psiquiatria (Sao Paulo,
Brazil : 1999) 25 (1): 26–30.
Caspi, Avshalom, Renate M. Houts, Antony Ambler, Andrea Danese, Maxwell L. Elliott,
Ahmad Hariri, Hona Lee Harrington, Sean Hogan, Richie Poulton, Sandhya
Ramrakha, Line J Hartmann Rasmussen, Aaron Reuben, Leah Richmond-Rakerd,
Karen Sugden, Jasmin Wertz, Benjamin S Williams, Terrie E Moffitt, 2020.
“Longitudinal Assessment of Mental Health Disorders and Comorbidities Across 4
Decades Among Participants in the Dunedin Birth Cohort Study.” JAMA Network
Open 3 (4): e203221.
Chapman, Susan A., Bethany J. Phoenix, Talia E. Hahn, and Deborah C. Strod. 2018.
“Utilization and Economic Contribution of Psychiatric Mental Health Nurse
Practitioners in Public Behavioral Health Services.” American Journal of Preventive
Medicine 54 (6 Suppl 3): S243–49.
Chau, Hang Sze, Wai Sun Chong, Josephine Grace Wing San Wong, Gabriel Bing Kei
Hung, Simon Sai Yu Lui, Sherry Kit Wa Chan, Wing Chung Chang, W. C., Hui, C.
L. M., Lee, E. H. M., McGorry, P. D., Jones, P. B., & Chen, E. Y. H., 2018. “Early
Intervention for Incipient Insanity: Early Notions from the 19 Th Century English
Literature.” Early Intervention in Psychiatry 12 (4): 708–14.
Clark, Cameron M. 2016. “Psychosocial Treatments for Schizophrenia: An Evaluation of
Theoretically Divergent Treatment Paradigms, and Their Efficacy.” Clinical
Schizophrenia & Related Psychoses 10 (1): 41–50. CSRP.CL.061213.
Coentre, Ricardo, Pedro Levy, and Maria Luísa Figueira. 2011. “[Early Intervention in
Psychosis: First-Episode Psychosis and Critical Period].” Acta Medica Portuguesa 24
(1): 117–26.
Cookey, Jacob, Candice E. Crocker, Denise Bernier, Aaron J. Newman, Sherry Stewart,
David McAllindon, and Philip G. Tibbo. 2018. “Microstructural Findings in White
Matter Associated with Cannabis and Alcohol Use in Early-Phase Psychosis: A
Diffusion Tensor Imaging and Relaxometry Study.” Brain Connectivity 8 (9): 567–76.
Cristóbal-Narváez, Paula, Tamara Sheinbaum, Araceli Rosa, Marta de Castro-Catala,
Tecelli Domínguez-Martínez, Thomas R. Kwapil, and Neus Barrantes-Vidal. 2020.
“Interaction of Both Positive and Negative Daily-Life Experiences with FKBP5
Haplotype on Psychosis Risk.” European Psychiatry : The Journal of the Association
of European Psychiatrists 63 (1).
Dam, D. S. Van, E. Van Der Ven, E. Velthorst, J. P. Selten, C. Morgan, and L. De Haan.
2012. “Childhood Bullying and the Association with Psychosis in Non-Clinical and
Clinical Samples: A Review and Meta-Analysis.” Psychological Medicine 42 (12):
Diagnóstico, Manual, Y Estadístico, and De Trastornos Mentales. 2017.
“ACTUALIZACIÓN Suplemento Del DSM-5 ® Septiembre 2016 [DSM-5 ®
Supplement UPDATE September 2016].” http://dsm.
Fernández, Juan, Joaquín Pereira, and Alberto Torres. 1995. “Una Agenda a Debate: El
Informe Del Banco Mundial ‘ Intervenir En Salud [An Agenda for Debate: The World
Bank Report ‘ Intervene in Health].’” Rev Esp Salud Pública 1995; 69 (5): 385–91.
Ferrando, Stephen J., Lidia Klepacz, Sean Lynch, Mohammad Tavakkoli, Rhea Dornbush,
Reena Baharani, Yvette Smolin, and Abraham Bartell. 2020. “COVID-19 Psychosis:
A Potential New Neuropsychiatric Condition Triggered by Novel Coronavirus
Infection and the Inflammatory Response?” Psychosomatics 61 (5): 551.
Fusar-Poli, Paolo, Gonzalo Salazar De Pablo, Christoph U. Correll, Andreas Meyer
Lindenberg, Mark J. Millan, Stefan Borgwardt, Silvana Galderisi, S., Bechdolf, A.,
Pfennig, A., Kessing, L. V., van Amelsvoort, T., Nieman, D. H., Domschke, K., Krebs,
M.-O., Koutsouleris, N., McGuire, P., Do, K. Q., & Arango, C., 2020. “Prevention of
Psychosis: Advances in Detection, Prognosis, and Intervention.” JAMA Psychiatry 77
(7): 755–65.
Henquet, Cécile, Araceli Rosa, Lydia Krabbendam, Sergi Papiol, Lourdes Faňanás, Marjan
Drukker, Johannes G. Ramaekers, and Jim Van Os. 2006. “An Experimental Study of
Catechol-O-Methyltransferase Val158Met Moderation of Δ-9-Tetrahydrocannabinol
Induced Effects on Psychosis and Cognition.” Neuropsychopharmacology 31 (12):
Ikiugu, Moses N., Ranelle M. Nissen, Cali Bellar, Alexya Maassen, and Katlin Van
Peursem. 2017. “Clinical Effectiveness of Occupational Therapy in Mental Health: A
Meta-Analysis.” The American Journal of Occupational Therapy 71 (5): 7105100020
Irving, Jessica, Craig Colling, Hitesh Shetty, Megan Pritchard, Robert Stewart, Paolo
Fusar-Poli, Philip McGuire, and Rashmi Patel. 2021. “Gender Differences in Clinical
Presentation and Illicit Substance Use during First Episode Psychosis: A Natural
Language Processing, Electronic Case Register Study.” BMJ Open 11 (4).
Isvoranu, Adela Maria, Sinan Guloksuz, Sacha Epskamp, Jim Van Os, and Denny
Borsboom. 2020. “Toward Incorporating Genetic Risk Scores into Symptom
Networks of Psychosis.” Psychological Medicine 50 (4): 636–43.
Lamberti, J. Steven, Viki Katsetos, David B. Jacobowitz, and Robert L. Weisman. 2020.
“Psychosis, Mania and Criminal Recidivism: Associations and Implications for
Prevention.” Harvard Review of Psychiatry 28 (3): 179–202.
Lee, Yu Jin, Seong Jin Cho, In Hee Cho, Joon Hwan Jang, and Seog Ju Kim. 2012. “The
Relationship between Psychotic-like Experiences and Sleep Disturbances in
Adolescents.” Sleep Medicine 13 (8): 1021–27.
Liu, Ping, Alexandra G. Parker, Sarah E. Hetrick, Patrick Callahan, Stefanie de Silva, and
Rosemary Purcell. 2010. “An Evidence Map of Interventions across Premorbid,
Ultra High Risk and First Episode Phases of Psychosis.” Schizophrenia Research 123 (1):
McGorry, Patrick D., Barnaby Nelson, Sherilyn Goldstone, and Alison R. Yung. 2010.
“Clinical Staging: A Heuristic and Practical Strategy for New Research and Better
Health and Social Outcomes for Psychotic and Related Mood Disorders.” Canadian
Journal of Psychiatry. Revue Canadienne de Psychiatrie 55 (8): 486–97.
Os, Jim Van, Bart P.F. Rutten, and Richie Poulton. 2008. “Gene-Environment Interactions
in Schizophrenia: Review of Epidemiological Findings and Future Directions.”
Schizophrenia Bulletin 34 (6): 1066–82.
Patel, Pooja K., Logan D. Leathem, Danielle L. Currin, and Katherine H. Karlsgodt. 2021.
“Adolescent Neurodevelopment and Vulnerability to Psychosis.” Biological
Psychiatry 89 (2): 184–93.
Petrou, Alexandra M, Jeremy R Parr, and Helen McConachie. 2018. “Gender Differences
in Parent-Reported Age at Diagnosis of Children with Autism Spectrum Disorder.”
Research in Autism Spectrum Disorders 50: 32–42.
Reeve, Sarah, Bryony Sheaves, and Daniel Freeman. 2015. “The Role of Sleep Dysfunction
in the Occurrence of Delusions and Hallucinations: A Systematic Review.” Clinical
Psychology Review 42 (December): 96.
Rocamora-Montenegro, Mariá, Laura Mariá Compañ-Gabucio, and Manuela Garcia De La
Hera. 2021. “Original Research: Occupational Therapy Interventions for Adults with
Severe Mental Illness: A Scoping Review.” BMJ Open 11 (10): 47467.
Stanton, Kate J., Brian Denietolis, Brien J. Goodwin, and Yael Dvir. 2020. “Childhood
Trauma and Psychosis: An Updated Review.” Child and Adolescent Psychiatric
Clinics of North America 29 (1): 115–29.
Terry-McElrath, Yvonne M., Patrick M. O’Malley, and Lloyd D. Johnston. 2013.
“Simultaneous Alcohol and Marijuana Use among U.S. High School Seniors from
1976 to 2011: Trends, Reasons, and Situations.” Drug and Alcohol Dependence 133
(1): 71–79.
Thompson, Kara, Maria Holley, Clea Sturgess, and Bonnie Leadbeater. 2021. “Co-Use of
Alcohol and Cannabis: Longitudinal Associations with Mental Health Outcomes in
Young Adulthood.” International Journal of Environmental Research and Public
Health 2021, Vol. 18, Page 3652 18 (7): 3652. 18073652.
Torres Ruíz, Antonio. 2003. P. 28-30 “Revista Neurología, Neurocirugía y Psiquiatría
[Neurology, Neurosurgery and Psychiatry Journal].” Neurol Neurocir Psiquiat 36 (1).
Tucker, Peter. 2009. “Substance Misuse and Early Psychosis.” Australasian Psychiatry :
Bulletin of Royal Australian and New Zealand College of Psychiatrists 17 (4): 291–94.
Varese, Filippo, Feikje Smeets, Marjan Drukker, Ritsaert Lieverse, Tineke Lataster,
Wolfgang Viechtbauer, John Read, Jim Van Os, and Richard P. Bentall. 2012.
“Childhood Adversities Increase the Risk of Psychosis: A Meta-Analysis of Patient Control,
Prospective- and Cross-Sectional Cohort Studies.” Schizophrenia Bulletin 38
(4): 661–71.
Volkow, Nora D., Gene Jack Wang, Frank Telang, Joanna S. Fowler, David Alexoff, Jean
Logan, Millard Jayne, Christopher Wong, and Dardo Tomasi. 2014. “Decreased
Dopamine Brain Reactivity in Marijuana Abusers Is Associated with Negative
Emotionality and Addiction Severity.” Proceedings of the National Academy of
Sciences of the United States of America 111 (30).
Watson, Cameron J., Rhys H. Thomas, Tom Solomon, Benedict Daniel Michael, Timothy
R. Nicholson, and Thomas A. Pollak. 2021. “COVID-19 and Psychosis Risk: Real or
Delusional Concern?” Neuroscience Letters 741 (January): 135491.
Weinstein, Aviv M., Paola Rosca, Liana Fattore, and Edythe D. London. 2017. “Synthetic
Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.”
Frontiers in Psychiatry 8 (AUG): 156.
Zwicker, Alyson, Eileen M. Denovan-Wright, and Rudolf Uher. 2018. “Gene-Environment
Interplay in the Etiology of Psychosis.” Psychological Medicine 48 (12): 1925–36.


Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!